Retatrutide 30mg
Triple Agonist Peptide for Metabolic Research
$199.99$179.99
Retatrutide is an investigational peptide for metabolic research, targeting obesity and type 2 diabetes. It acts as a triple agonist on GLP-1, GIP, and glucagon receptors, improving glucose control and reducing weight. It enhances insulin sensitivity, suppresses appetite, and boosts energy use. Retatrutide is for laboratory research only, not for human use.